ADAMS KENDRA (Chief Financial Officer) received a stock award from C4 THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/18/2026ACC: 0001470831-26-000175
Officer· Chief Financial Officer
Since Feb 2026
+257.46K
Net shares
Net buyer
$32.6K
Total sold
0
Open market trades
0B · 0S
5
Total transactions
274.70K acquired · 17.24K disposed
Non-Derivative Transactions5
Common Stock
Direct
Shares
+240K
Price / share
—
Trade value
—
% of position
147.8%
2/13/2026
162.34K→402.34K
Common Stock
Direct
Shares
+3.75K
Price / share
—
Trade value
—
% of position
0.9%
2/13/2026
398.59K→402.34K
Common Stock
Direct
Shares
−1.86K
Price / share
$1.89
Trade value
$3.52K
% of position
0.5%
2/13/2026
402.34K→400.48K
Common Stock
Direct
Shares
+30.95K
Price / share
—
Trade value
—
% of position
8.4%
2/14/2026
369.53K→400.48K
Common Stock
Direct
Shares
−15.38K
Price / share
$1.89
Trade value
$29.07K
% of position
3.8%
2/14/2026
400.48K→385.10K
Total
Net shares
+257.46K
Net value
-$32.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/13/2026 | A · Award | +240K | — | — | 147.8% | 162.34K | 402.34K |
| Common Stock Direct | 2/13/2026 | M · Option Exercise | +3.75K | — | — | 0.9% | 398.59K | 402.34K |
| Common Stock Direct | 2/13/2026 | F · Tax Withholding | −1.86K | $1.89 | $3.52K | 0.5% | 402.34K | 400.48K |
| Common Stock Direct | 2/14/2026 | M · Option Exercise | +30.95K | — | — | 8.4% | 369.53K | 400.48K |
| Common Stock Direct | 2/14/2026 | F · Tax Withholding | −15.38K | $1.89 | $29.07K | 3.8% | 400.48K | 385.10K |
| Total | +257.46K | -$32.59K | ||||||
Derivative Transactions0
No derivative transactions reported